Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $690.04 | 3 | 63.7% |
| Food and Beverage | $393.64 | 17 | 36.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Integra LifeSciences Corporation | $705.19 | 4 | $0 (2024) |
| Eclipse Technology Solutions Inc. | $70.72 | 1 | $0 (2024) |
| Misonix Inc | $48.89 | 1 | $0 (2021) |
| Organogenesis Inc. | $43.16 | 2 | $0 (2024) |
| Smith+Nephew, Inc. | $34.81 | 2 | $0 (2024) |
| OVIK Health, LLC | $27.35 | 1 | $0 (2024) |
| Orthofix Medical, Inc. | $25.71 | 1 | $0 (2024) |
| Stryker Corporation | $25.35 | 2 | $0 (2021) |
| DePuy Synthes Sales Inc. | $20.06 | 1 | $0 (2022) |
| Novo Nordisk Inc | $19.52 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $897.96 | 10 | Integra LifeSciences Corporation ($690.04) |
| 2023 | $13.58 | 1 | Nevro Corp. ($13.58) |
| 2022 | $97.90 | 6 | DePuy Synthes Sales Inc. ($20.06) |
| 2021 | $74.24 | 3 | Misonix Inc ($48.89) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Organogenesis Inc. | APLIGRAF (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: WOUND CARE | ||||||
| 12/02/2024 | Orthofix Medical, Inc. | Physio-Stim (Device) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 11/11/2024 | Integra LifeSciences Corporation | ACell (Device) | Long term medical supply or device loan | In-kind items and services | $356.74 | General |
| Category: Recon-Skin and Wound | ||||||
| 11/11/2024 | Integra LifeSciences Corporation | ACell (Device) | Long term medical supply or device loan | In-kind items and services | $245.39 | General |
| Category: Recon-Skin and Wound | ||||||
| 11/11/2024 | Integra LifeSciences Corporation | ACell (Device) | Long term medical supply or device loan | In-kind items and services | $87.91 | General |
| Category: Recon-Skin and Wound | ||||||
| 11/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | OVIK Health, LLC | Coflex TLC (Device) | Food and Beverage | Cash or cash equivalent | $27.35 | General |
| Category: WOUND DRESSING | ||||||
| 10/16/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Pharma Products | ||||||
| 07/17/2024 | Eclipse Technology Solutions Inc. | — | Food and Beverage | In-kind items and services | $70.72 | General |
| 07/16/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $27.16 | General |
| 09/27/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/17/2022 | Smith+Nephew, Inc. | REGRANEX (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Pharma Products | ||||||
| 10/03/2022 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Recon-Skin and Wound | ||||||
| 09/12/2022 | DePuy Synthes Sales Inc. | N/A (Device), NA, MOTOBAND | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Orthopedics | ||||||
| 06/29/2022 | Paragon 28, Inc. | PRODUCT PORTFOLIO (Device) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: FOOT AND ANKLE IMPLANTS | ||||||
| 06/02/2022 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Wound Care | ||||||
| 01/12/2022 | BioTissue Holdings, Inc. | NEOX (Medical Supply), CLARIX | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 08/27/2021 | Stryker Corporation | ASNIS (Device), ANCHORAGE | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 07/27/2021 | Stryker Corporation | ORTHOLOC 2 LAPIFUSE (Device) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 05/25/2021 | Misonix Inc | NeXus (Device) | Food and Beverage | In-kind items and services | $48.89 | General |
| Category: Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 315 | 721 | $104,590 | $47,033 |
| 2022 | 11 | 402 | 704 | $101,166 | $44,747 |
| 2021 | 6 | 161 | 263 | $30,360 | $15,428 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 274 | $41,250 | $17,999 | 43.6% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 40 | 124 | $17,390 | $8,307 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 93 | $13,350 | $6,914 | 51.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 63 | $15,700 | $6,832 | 43.5% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 40 | 119 | $9,255 | $4,101 | 44.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,250 | $1,525 | 35.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 19 | $2,375 | $785.65 | 33.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,020 | $568.82 | 55.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 177 | $29,078 | $10,543 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 116 | $14,582 | $8,813 | 60.4% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 48 | 114 | $13,945 | $7,900 | 56.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 55 | $15,880 | $6,211 | 39.1% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 42 | 103 | $8,015 | $3,847 | 48.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $7,950 | $2,865 | 36.0% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2022 | 12 | 15 | $2,925 | $1,426 | 48.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 26 | 35 | $3,876 | $1,132 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 21 | $1,785 | $1,040 | 58.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 15 | 15 | $2,625 | $956.10 | 36.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 21 | $505.00 | $15.44 | 3.1% |
| 11056 | Removal of 2 to 4 thickened skin growths | Office | 2021 | 37 | 70 | $6,960 | $4,934 | 70.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 55 | $6,875 | $4,240 | 61.7% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2021 | 37 | 73 | $5,735 | $2,754 | 48.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $7,750 | $2,680 | 34.6% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 15 | 15 | $2,625 | $800.98 | 30.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 12 | 19 | $415.00 | $19.37 | 4.7% |
About Kyle Shaw
Kyle Shaw is a Podiatrist healthcare provider based in Upper Darby, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2017. The National Provider Identifier (NPI) number assigned to this provider is 1710410899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kyle Shaw has received a total of $1,084 in payments from pharmaceutical and medical device companies, with $897.96 received in 2024. These payments were reported across 20 transactions from 14 companies. The most common payment nature is "Long term medical supply or device loan" ($690.04).
As a Medicare-enrolled provider, Shaw has provided services to 878 Medicare beneficiaries, totaling 1,688 services with total Medicare billing of $107,208. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Podiatrist
- Other Specialties Podiatrist
- Location Upper Darby, PA
- Active Since 04/06/2017
- Last Updated 08/28/2020
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1710410899
Products in Payments
- ACell (Device) $690.04
- NeXus (Device) $48.89
- Coflex TLC (Device) $27.35
- Physio-Stim (Device) $25.71
- COLLAGENASE SANTYL (Drug) $21.46
- N/A (Device) $20.06
- Rybelsus (Drug) $19.52
- PRODUCT PORTFOLIO (Device) $17.37
- Restrata Wound Matrix (Device) $16.24
- APLIGRAF (Device) $16.00
- NEOX (Medical Supply) $15.73
- Integra (Device) $15.15
- ORTHOLOC 2 LAPIFUSE (Device) $14.10
- Senza (Device) $13.58
- REGRANEX (Drug) $13.35
- ASNIS (Device) $11.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.